Natrilix (Indapamide)

Indapamide blocks the sodium‑chloride transporter in the distal convoluted tubule of the kidney, decreasing reabsorption of these ions. This promotes loss of sodium, chloride, and water in the urine, reducing blood volume and peripheral vascular resistance, which together lower blood pressure.

The appropriate dose of Natrilix is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and renal function. Patients should follow the exact dosage instructions provided by their healthcare professional.

Safety data for indapamide in pregnancy and lactation are limited, and the product is generally classified as contraindicated or to be used only if the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their physician.

To request Natrilix, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indapamide offers a longer half‑life and a more pronounced vasodilatory effect compared with traditional thiazides such as hydrochlorothiazide. This can provide smoother blood‑pressure control and may be associated with a lower incidence of metabolic side effects, though individual response varies.

Natrilix tablets should be stored at room temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the medication out of reach of children and do not use after the expiration date.

Natrilix is taken orally, usually once daily in the morning with or without food, as directed by the prescriber. Swallow the tablet whole with a full glass of water; do not crush or chew unless specifically instructed.

Serious risks include severe dehydration, electrolyte disturbances such as hypokalemia or hyponatremia, and rare allergic reactions like angioedema. Patients should be monitored for signs of dizziness, muscle weakness, irregular heartbeat, or rash, and seek medical attention promptly if they occur.

Natrilix is contraindicated in patients with anuria, severe renal impairment, or known hypersensitivity to indapamide or other sulfonamide-derived drugs. Caution is also advised for individuals with uncontrolled gout, severe hepatic disease, or those taking interacting medications without proper monitoring.